| Robert Duane Porter, | |
|
20 State Highway 319, Belfry, KY 41514-8678 | |
| (606) 237-0555 | |
| (606) 237-1069 |
| Full Name | Robert Duane Porter |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 20 State Highway 319, Belfry, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427649359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 010650 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Duane Porter, Po Box 245, Belfry, KY 41514-0245 Ph: (606) 237-0555 | Robert Duane Porter, 20 State Highway 319, Belfry, KY 41514-8678 Ph: (606) 237-0555 |
News Archive
A number of herbs and dietary supplements (HDS) can cause potentially harmful drug interactions, particularly among people receiving medication for problems with their central nervous or cardiovascular systems.
Stemline Therapeutics, Inc. today announced that two abstracts featuring SL-401 clinical efficacy in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), and pre-clinical activity in chronic myeloid leukemia (CML) have been selected for presentation at the upcoming 52nd Annual Meeting of the American Society of Hematology (ASH) to be held in Orlando, FL from December 4-7, 2010.
As the 64th World Health Assembly gets underway in Geneva, the body will consider "an array of subjects pertaining to reforms of the organisation and its financing, vaccines, fake medicines, and influenza pandemic preparedness, as well as communicable and non-communicable diseases," Intellectual Property Watch reports.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
Malawi plans to provide 150,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year, Biziwick Mwale, chief of the National AIDS Commission, said on Monday, AFP/Sunday Times reports.
› Verified 5 days ago
Dr. Nichole Reid, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 State Highway 319, Belfry, KY 41514 Phone: 606-237-0555 Fax: 606-237-1069 |